Catalent licenses NJIT’s taste-making technology to mask unpleasant and bitter medicines

Published on October 11, 2012 at 8:15 AM · 1 Comment

Following a successful research collaboration with NJIT, Catalent Pharma Solutions of Somerset has announced that it has exclusively licensed innovative taste-making technology developed by NJIT Distinguished Professor Rajesh Dav-, who was the principal investigator of a research project funded by Catalent. The technology will mask the most challenging, unpleasant and bitter tasting pharmaceutical active ingredients.

Under the terms of the license, Catalent will complete transfer of the technology into its world class, cGMP facilities to support manufacture of novel dosage forms such as its Zydis- fast dissolve platform. It is expected that the taste-masking technology will be effective for developing a wide variety of formulations including granules/sachets, sprinkles, chewables, effervescent and oral dispersible tablets.

"Taste-masking of fine drug particles has remained an un-met technical challenge for formulators," said Dav-. "Through funding from Catalent we have been able to leverage our expertise to innovate technology and processes that allow for these materials to be cost effectively coated and taste-masked. This is a significant achievement for our team that included two highly-talented graduate students who delivered solutions to the Catalent challenge on time while developing strong fundamental science that would lead to journal articles."

Dav- is a long-time faculty member of Newark College of Engineering's Department of Chemical, Biological and Pharmaceutical Engineering at NJIT.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
  1. Goutam Ghosh Goutam Ghosh India says:

    Dr Dave'has achieved what had been bugging the medical technology world so far -- coating drugs at the particulate level.

    The discovery will certainly help people whose health status dictates the need to swallow pills which leave a very unpleasant taste in the mouth, even when swallowed quickly.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post